- Home
- ZYME vs LPG Comparison
ZYME vs LPG Comparison
Compare ZYME & LPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- LPG
- Stock Information
- Founded
- ZYME 2003
- LPG 2013
- Country
- ZYME United States
- LPG United States
- Employees
- ZYME N/A
- LPG N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- LPG Marine Transportation
- Sector
- ZYME Health Care
- LPG Consumer Discretionary
- Exchange
- ZYME Nasdaq
- LPG Nasdaq
- Market Cap
- ZYME 983.6M
- LPG 913.3M
- IPO Year
- ZYME 2017
- LPG 2014
- Fundamental
- Price
- ZYME $11.62
- LPG $22.11
- Analyst Decision
- ZYME Buy
- LPG Strong Buy
- Analyst Count
- ZYME 6
- LPG 1
- Target Price
- ZYME $19.50
- LPG $35.00
- AVG Volume (30 Days)
- ZYME 718.6K
- LPG 775.1K
- Earning Date
- ZYME 05-01-2025
- LPG 05-21-2025
- Dividend Yield
- ZYME N/A
- LPG 16.73%
- EPS Growth
- ZYME N/A
- LPG N/A
- EPS
- ZYME N/A
- LPG 3.87
- Revenue
- ZYME $76,304,000.00
- LPG $416,947,918.00
- Revenue This Year
- ZYME $26.29
- LPG N/A
- Revenue Next Year
- ZYME $75.78
- LPG $10.11
- P/E Ratio
- ZYME N/A
- LPG $5.72
- Revenue Growth
- ZYME 0.38
- LPG N/A
- 52 Week Low
- ZYME $7.97
- LPG $19.36
- 52 Week High
- ZYME $17.70
- LPG $51.66
- Technical
- Relative Strength Index (RSI)
- ZYME 37.79
- LPG 47.60
- Support Level
- ZYME $12.15
- LPG $21.67
- Resistance Level
- ZYME $13.28
- LPG $23.85
- Average True Range (ATR)
- ZYME 0.59
- LPG 0.64
- MACD
- ZYME -0.02
- LPG 0.06
- Stochastic Oscillator
- ZYME 7.33
- LPG 39.16
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece.